Rm2 Share Discussion Threads

[dr biotech] 30/6/2017 19:57

Purplebricks has done rather well though. I am guessing the CEO had to fall on his sword here to get the placing away. Not surprising, he has burned through a lot of shareholder funds here through incompetence and wishful thinking. FWIW i still think the pallets are a good idea, but I won't be back anytime soon.

[phowdo] 30/6/2017 17:00

Woodford sure does pick some duff stocks - this and GMD have both been utter stinkers.

[dr biotech] 30/6/2017 16:32

Glad I'm out. Also glad the clown of a CEO has gone, he should have been sacked last year though. Feel
Sorry for those left holding the baby.

[dr biotech] 26/6/2017 07:27

Results due by 30th. Perhaps they will give us the update they promised for Q1. Can't say I am optimistic. The lack of info treats their shareholders with contempt. Seems they will only tak to them when they have to by law...we were promised an update Q1 it will be Q3....

[rob1ng] 31/5/2017 08:11

Maybe rm2 bottomed around 18p hope so cause I averaged down

[dr biotech] 17/5/2017 11:34

The manufacturing was incompetence at is worst - unsuitable design (coating) and they couldn't make enough or at the right price. The factory has shut and the equipment was shipped off to China. I'd love to be able to give an update on how that has gone - we were promised one in Q1 but that was just more management BS (along with updates on sales). Unfortunately no communication equates with lack of progress.

[dr biotech] 17/5/2017 10:24

Think they are just embarassed at what a shambles this company is. Disastrous production obviously no1, but their communications to shareholders is also inept. RNS are poorly written and have typos - so does their presentation on the Eliot pallet.

Product is good - it can still be a winner. I actually still have 2k invested as a token amount in the Mrs account, but my smallest holding of anything.

[scemer] 17/5/2017 08:59

Dr B from the 2015 accounts The non-executive directors of the Company have elected to receive 2016 board fees in the form of 10-year options vesting after three years and granted at fair market value, exercisable only when the average closing price of the shares exceeds 100p for thirty days. These options are expected to be issued in the next open market window.Hopefully a lot of work in the background

[dr biotech] 11/5/2017 12:30

The article on the weblink is appalling. Poorly researched and even more poorly written. I assume that English is not the first language of the author

Anyone who is remotely interested (and for the record I no longer hold a position here) - the large cash burn was mostly in setting up and developing their own production. This has now closed and they are made by 3rd parties which will bring down the costs and overheads. You can find the answers to your questions in the RNS statements released about this time last year.

The "research" on the prices of pallets is hilarious. You are comparing a new fibreglass resuable, pharmaceutical safe pallet, with a knackered wooden one on Ebay.

I don't trust the RM2 management to deliver, but I'd trust any article on that website even less.

[montyhedge] 11/5/2017 12:14

To me they tried to solve a problem thats not really there, nothing wrong with wood and substainable wood at that.

[walbrock82] 11/5/2017 12:11

Either this company is a dud or it went to the market at the wrong time. Nonetheless, they didn’t deliver for shareholders as shares are 75% lower than IPO’s price of 88 pence.

Consider these two facts; -
A. Since 2013, total operating loss came to $157m, or £120m;
B. Cash balance went from $115m to $4m in two and a half years.

We will know how much revenue has grown by late June.
Despite the latest deal with Pactiv LLC, the share price didn’t response. To be honest, I expect further financing meaning more share price dilution!
For more, check out the post which covers the following: Cost of a wooden pallet, the correlation between share price and cash, Neil Woodford, etc. (

Some people would argue that RM2 Intl. needs to reach an economy of scale for it to become profitable. That might be true, but we all know it is a long way off!

For those who are evaluating RM2 Intl, ask yourself these questions:
A. What is the breakeven point?
B. How many sales does it need to produce annually to break even?
C. Will the costs come down enough to make RM2 a viable investment proposition?

[pugugly] 09/5/2017 11:37

Sorry to see you go Dr B - Your input especially re demand for hygienic pallets was useful BUT (apart from the odd -to date - profitable punt) I was put off by the "know it all" attitude of management when challenged and it was clear (to me) that they were lacking in shop floor experience

[dr biotech] 09/5/2017 09:25

I have given up here. Lack of communication on manufacturing and customers. Will keep a watch on them though as the potential is huge

[pugugly] 05/5/2017 16:41

monty - you may well get it - Punt time (imo) from 20p downwards - The bIG gamble is where .......... or will it all end up in Carey Street.

[montyhedge] 04/5/2017 15:59

I will have a punt at 5p after the figures.

[kendonagasaki] 04/5/2017 15:21

The charts indicate a futher fall here.15p will be touched here, its in free fall here!

[nw99] 19/4/2017 13:14

Its a buy all day long here

[tdog1975] 18/4/2017 10:20

Closed my short this morning... to early???? I don't know but feels about right

[pugugly] 13/4/2017 16:32

Could be approaching "GAMBLE TIME" though not for widows orphans or trusts !!!

[dr biotech] 12/4/2017 20:44

A lot of places need a declaration of no wood packaging. Plastic covered wood is still wood. Risks bacterial contamination etc. RM2 pallets are heavier, they are also stronger and more expensive. So they are not for single use or low cost light goods etc, but they are very good for closed food chains etc where they can be cleaned and tracked.

Plastic pallets can also weaken with heat..there is no perfect solution